Optimal sampling of pelvic lymphadenectomy specimens following radical prostatectomy: is complete tissue submission justified?
lymph node
lymphadenectomy
prostate cancer
Journal
Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
13
03
2019
revised:
22
04
2019
accepted:
23
04
2019
pubmed:
4
6
2019
medline:
16
10
2019
entrez:
3
6
2019
Statut:
ppublish
Résumé
There is currently no consensus among pathologists on the optimal method of sampling pelvic lympadenectomy specimens (PLND) in prostate cancer. We evaluated the impact of complete PLND submission on lymph node (LN) yield, detection of metastasis and laboratory workload in a series of 141 cases. Following isolation of grossly identifiable LNs/potential LNs, the remaining fatty tissue was embedded in toto. Complete PLND submission increased median LN yield from 10 (1-42) to 17 (3-57). Metastatic deposits were identified in nine non-palpable LNs, which altered the pN category in four cases (3%). The primary tumour (pT) was grade group ≥3 and/or pT3 at radical prostatectomy in 96% of pN+ cases. A median of seven additional blocks (1-28) was required for complete tissue embedding. Our findings indicate that submission of the entire fat can optimise PLND assessment but has a significant impact on laboratory workload. Complete submission of selected high-risk cases may be a reasonable alternative.
Identifiants
pubmed: 31154422
pii: jclinpath-2019-205839
doi: 10.1136/jclinpath-2019-205839
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
712-715Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.